BHVN

Biohaven Pharmaceutical Holding Company Ltd.

Delisted

BHVN was delisted on the 3rd of October, 2022.

226 hedge funds and large institutions have $4.34B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2020 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
226
Holders Change
+51
Holders Change %
+29.14%
% of All Funds
4.65%
Holding in Top 10
16
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+60%
% of All Funds
0.33%
New
67
Increased
77
Reduced
63
Closed
15
Calls
$160M
Puts
$37.7M
Net Calls
+$122M
Net Calls Change
+$22M
Name Holding Trade Value Shares
Change
Shares
Change %
FCMI
226
Foresite Capital Management IV
California
-$5.32M -156,355 Closed
FCMI
227
Foresite Capital Management III
California
-$2.12M -62,245 Closed
TMC
228
Trellus Management Company
Florida
-$851K -25,000 Closed
BG
229
Bellevue Group
Switzerland
-$844K -24,800 Closed
Squarepoint
230
Squarepoint
New York
-$688K -20,213 Closed
Tudor Investment Corp
231
Tudor Investment Corp
Connecticut
-$647K -19,004 Closed
SIM
232
Spark Investment Management
New York
-$401K -11,800 Closed
AG
233
Algert Global
California
-$249K -7,303 Closed
Capital Fund Management (CFM)
234
Capital Fund Management (CFM)
France
-$242K -7,115 Closed
CG
235
Cutler Group
California
-$162K -4,762 Closed
Simplex Trading
236
Simplex Trading
Illinois
-$148K -4,357 Closed
CL
237
CSS LLC
Illinois
-$95K -2,781 Closed
OAM
238
Oppenheimer Asset Management
New York
-$91K -2,681 Closed
ASN
239
Advisory Services Network
Georgia
-$2K -48 Closed
NFG
240
Next Financial Group
Texas
-$1K -24 Closed